UBT251
Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity
The United Bio-Technology (Hengqin) Co · Phase 1 · Recruiting · Enrollment 48
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| UBT251 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.